Vise Technologies’s Evolent Health EVH Stock Holding History

Vise Technologies’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$49.6K	Hold	12,399	–	–	﹤0.01%	1439
2025 Q4	$49.6K	Buy	+12,399	New	+$68.9K	﹤0.01%	1452

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vise Technologies's EVH Position: Q1 2026 in Review

Vise Technologies held its Evolent Health (EVH) position steady in Q1 2026 at 12,399 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1439.

Vise Technologies first reported a position in EVH in Q4 2025 and has held it in 2 quarters since. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Vise Technologies held 12,399 shares of Evolent Health worth $49.6K as of Q1 2026.
Vise Technologies left its Evolent Health share count unchanged in Q1 2026.
Evolent Health made up ﹤0.01% of Vise Technologies's portfolio in Q1 2026, its #1439 holding.
Vise Technologies first reported a position in Evolent Health in Q4 2025 and has held it in 2 quarters since.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.